The anti-inflammatory effects of anti-HMGB1 antibody on pilocarpine-induced epilepsy in mice

被引：0
|
作者：
Fu, Li [1 ]
Liu, Keyue [1 ]
Wake, Hidenori [1 ]
Teshigawara, Kiyoshi [1 ]
Mori, Shuji [2 ]
Nishibori, Masahiro [1 ]
机构：
[1] Okayama Univ, Sch Med, Dept Pharmacol, Okayama, Japan
[2] Shujitsu Univ, Sch Pharm, Dept Pharm, Okayama, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2016年 / 130卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
3-O-86
引用
收藏
页码：S132 / S132
页数：1
相关论文
共 50 条
  • [31] Anti-HMGB1 therapy for visceral pain
    Tsubota, Maho
    Kawabata, Atsufumi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 128 (03) : S40 - S40
  • [32] Anti-Inflammatory Effects of Lysozyme Against HMGB1 in Human Endothelial Cells and in Mice
    Wonhwa Lee
    Sae-Kwang Ku
    Dong Hee Na
    Jong-Sup Bae
    Inflammation, 2015, 38 : 1911 - 1924
  • [33] Humanized anti-HMGB1 antibody therapy attenuates in vivo acetaminophen-induced liver injury
    Lea, Jon
    Lundback, Peter
    Ottosson, Lars
    Sharkey, Jack
    Sowinska, Agnieszka
    Palmblad, Karin
    Clarke, Joanna
    Park, B. Kevin
    Andersson, Ulf
    Harris, Helena
    Antoine, Daniel
    TOXICOLOGY LETTERS, 2014, 229 : S69 - S70
  • [34] Annexin A1-derived peptide Ac2-26 in a pilocarpine-induced status epilepticus model: anti-inflammatory and neuroprotective effects
    Gimenes, Alexandre D.
    Andrade, Bruna F. D.
    Pinotti, Jose Victor P.
    Oliani, Sonia M.
    Galvis-Alonso, Orfa Y.
    Gil, Cristiane D.
    JOURNAL OF NEUROINFLAMMATION, 2019, 16 (1)
  • [35] Annexin A1-derived peptide Ac2-26 in a pilocarpine-induced status epilepticus model: anti-inflammatory and neuroprotective effects
    Alexandre D. Gimenes
    Bruna F. D. Andrade
    José Victor P. Pinotti
    Sonia M. Oliani
    Orfa Y. Galvis-Alonso
    Cristiane D. Gil
    Journal of Neuroinflammation, 16
  • [36] Anti-HMGB1 monoclonal antibody protects BBB from ischemia-induced disruption in rats
    Nishibori, Masahiro
    Zhang, Jiyong
    Liu, Keyue
    Wake, Hidenori
    Takahashi, Hideo
    Mori, Shuji
    Ohtsuka, Aiji
    NEUROSCIENCE RESEARCH, 2011, 71 : E406 - E406
  • [37] Preventive or therapeutic effects of anti-HMGB1 neutralizing antibody and recombinant human soluble thrombomodulin in rats with neuropathy induced by vincristine
    Nishida, Takeshi
    Kawaishi, Yudai
    Yamanishi, Hiroki
    Tsubota, Maho
    Sekiguchi, Fumiko
    Ishikura, Hiroyasu
    Nishibori, Masahiro
    Kawabata, Atsufumi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 : 101P - 101P
  • [38] Design of an Anti-HMGB1 Synthetic Antibody for In Vivo Ischemic/Reperfusion Injury Therapy
    Koide, Hiroyuki
    Kiyokawa, Chiaki
    Okishima, Anna
    Saito, Kaito
    Yoshimatsu, Keiichi
    Fukuta, Tatsuya
    Hoshino, Yu
    Asai, Tomohiro
    Nishimura, Yuri
    Miura, Yoshiko
    Oku, Naoto
    Shea, Kenneth J.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2023, 145 (42) : 23143 - 23151
  • [39] A Monoclonal Anti-HMGB1 Antibody Attenuates Neurodegeneration in an Experimental Animal Model of Glaucoma
    Tonner, Henrik
    Hunn, Selina
    Auler, Nadine
    Schmelter, Carsten
    Beutgen, Vanessa M.
    von Pein, Harald D.
    Pfeiffer, Norbert
    Grus, Franz H.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (08)
  • [40] Anti-HMGB1 monoclonal antibody therapy for a wide range of CNS and PNS diseases
    Nishibori, Masahiro
    Mori, Shuji
    Takahashi, Hideo K.
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2019, 140 (01) : 94 - 101
12345